MCM
COLL icon

Massar Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Massar Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,317
Closed -$431K – 274
2025
Q4 		$431K Buy
+9,317
New +$390K 0.05% 220

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Massar Capital Management's COLL Position: Q1 2026 in Review

Massar Capital Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 9,317 shares — an estimated $431K sold.

Massar Capital Management first reported a position in COLL in Q4 2025 and held it in 1 quarter. The position peaked at $431K in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Massar Capital Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Massar Capital Management sold 9,317 Collegium Pharmaceutical shares in Q1 2026, an estimated $431K.
  • Massar Capital Management first reported a position in Collegium Pharmaceutical in Q4 2025 and held it in 1 quarter.
  • Massar Capital Management's Collegium Pharmaceutical position peaked at $431K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Massar Capital Management's 13F filing for Q1 2026, filed 15 May 2026.